Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CAVA Group, Inc.(CAVA) | 9,507,990 | 9,507,990 | 0 | $800.86M | $574.38M | 75.75% | -$226.48M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 136,180,481 | 136,180,481 | 0 | $129.37M | $183.84M | 24.25% | +$54.47M |